Non-invasive tests for liver disease severity and the hepatocellular carcinoma risk in chronic hepatitis B patients with low-level viremia.
Namyoung PaikDong Hyun SinnJi H LeeIn S OhJung Hee KimWonseok KangGeum-Youn GwakYong-Han PaikMoon S ChoiJoon H LeeKwang C KohSeung W PaikPublished in: Liver international : official journal of the International Association for the Study of the Liver (2017)
The combined use of two non-invasive serum biomarkers (APRI and FIB-4) could stratify HCC risk for chronic HBV-infected patients with LLV.